USANA Health Sciences, Inc.

Informe acción NYSE:USNA

Capitalización de mercado: US$836.4m

USANA Health Sciences Dirección

Dirección controles de criterios 3/4

El CEO de USANA Health Sciences' es Jim Brown , nombrado en Nov 2016, tiene una permanencia de 7.42 años. compensación anual total es $2.47M, compuesta por 28.7% salario y 71.3% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.05% de las acciones de la empresa, por valor de $432.23K. La antigüedad media del equipo directivo y de la junta directiva es de 7.2 años y 6.1 años, respectivamente.

Información clave

Jim Brown

Chief Executive Officer (CEO)

US$2.5m

Compensación total

Porcentaje del salario del CEO28.7%
Permanencia del CEO7.4yrs
Participación del CEO0.05%
Permanencia media de la dirección7.2yrs
Promedio de permanencia en la Junta Directiva6.1yrs

Actualizaciones recientes de la dirección

Recent updates

USANA Health Sciences, Inc.'s (NYSE:USNA) Prospects Need A Boost To Lift Shares

Apr 04
USANA Health Sciences, Inc.'s (NYSE:USNA) Prospects Need A Boost To Lift Shares

USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital

Feb 08
USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital

Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?

Jan 06
Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?

USANA: New Digital Tools And Solid Balance Sheet Imply Undervaluation

Oct 23

Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?

Sep 09
Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?

Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital

Jul 27
Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital

USANA Earnings Preview: From China's Challenge To India's Promise

Jul 21

USANA Health Sciences says Brown will transition to CEO in July 2023

Feb 13

Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture

Feb 02
Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture

USANA Health Sciences down 17% after revising 2022 outlook below consensus estimates

Oct 25

Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return

Oct 18
Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return

Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?

Jul 22
Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?

Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled

Jul 07
Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled

Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?

Jun 14
Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?

Is USANA Health Sciences, Inc. (NYSE:USNA) Potentially Undervalued?

May 31
Is USANA Health Sciences, Inc. (NYSE:USNA) Potentially Undervalued?

USANA: Soft Quarter, Bottomed Out Stock, 9.8x Ex-Cash P/E, 65% Upside

Apr 28

Capital Investments At USANA Health Sciences (NYSE:USNA) Point To A Promising Future

Mar 05
Capital Investments At USANA Health Sciences (NYSE:USNA) Point To A Promising Future

USANA: 15x P/E, 14% Net Cash, Stock Repurchases

Feb 17

A Look At The Intrinsic Value Of USANA Health Sciences, Inc. (NYSE:USNA)

Jan 24
A Look At The Intrinsic Value Of USANA Health Sciences, Inc. (NYSE:USNA)

At US$99.77, Is It Time To Put USANA Health Sciences, Inc. (NYSE:USNA) On Your Watch List?

Jan 11
At US$99.77, Is It Time To Put USANA Health Sciences, Inc. (NYSE:USNA) On Your Watch List?

Here's Why I Think USANA Health Sciences (NYSE:USNA) Might Deserve Your Attention Today

Nov 15
Here's Why I Think USANA Health Sciences (NYSE:USNA) Might Deserve Your Attention Today

USANA: Q3 Mixed Results, We See 35% Upside, 15% 10-Year EPS CAGR

Oct 28

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Jim Brown en comparación con los beneficios de USANA Health Sciences?
FechaCompensación totalSalarioIngresos de la empresa
Dec 30 2023US$2mUS$710k

US$64m

Sep 30 2023n/an/a

US$60m

Jul 01 2023n/an/a

US$63m

Apr 01 2023n/an/a

US$65m

Dec 31 2022US$2mUS$624k

US$69m

Oct 01 2022n/an/a

US$77m

Jul 02 2022n/an/a

US$89m

Apr 02 2022n/an/a

US$108m

Jan 01 2022US$2mUS$600k

US$117m

Oct 02 2021n/an/a

US$136m

Jul 03 2021n/an/a

US$139m

Apr 03 2021n/an/a

US$129m

Jan 02 2021US$2mUS$599k

US$125m

Sep 26 2020n/an/a

US$116m

Jun 27 2020n/an/a

US$110m

Mar 28 2020n/an/a

US$103m

Dec 28 2019US$2mUS$559k

US$101m

Sep 28 2019n/an/a

US$102m

Jun 29 2019n/an/a

US$109m

Mar 30 2019n/an/a

US$121m

Dec 29 2018US$2mUS$534k

US$126m

Sep 29 2018n/an/a

US$88m

Jun 30 2018n/an/a

US$81m

Mar 31 2018n/an/a

US$70m

Dec 30 2017US$1mUS$523k

US$63m

Compensación vs. Mercado: La compensación total ($USD2.47M) de Jim está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD3.44M).

Compensación vs. Ingresos: La compensación de Jim ha aumentado más de un 20%, mientras que los beneficios de la empresa han caído más de un 20% en el último año.


CEO

Jim Brown (54 yo)

7.4yrs

Permanencia

US$2,472,017

Compensación

Mr. Jim Brown has been the President of USANA Health Sciences Inc. since November 2016 and served as its Chief Operating Officer since November 2013 until October 2019. He serves as Chief Executive Officer...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Kevin Guest
Executive Chairman6.9yrsUS$3.91m0.063%
$ 529.3k
Jim Brown
CEO & President7.4yrsUS$2.47m0.050%
$ 419.9k
G. Hekking
Chief Financial Officer6.9yrsUS$1.47m0.034%
$ 286.6k
Walter Noot
Chief Operating Officer4.5yrsUS$1.42msin datos
P. Foukas
Chief Legal Officer5.8yrsUS$1.29msin datos
Daniel Macuga
Chief Communications & Marketing Officer12.3yrsUS$1.15m0.029%
$ 246.1k
Myron Wentz
Founder & Chairman Emeritus32.3yrssin datos40.97%
$ 342.7m
John Cuomo
Executive Director of Product Development & Technology11.3yrssin datossin datos
Robert Sinnott
Chief Scientific Officer7.7yrssin datossin datos
Patrique Richards
Executive Director of Investor Relations & Business Developmentno datasin datossin datos
Paul Jones
Chief People Officer3.2yrsUS$637.78k0.047%
$ 390.3k
Ashley Collins
Executive Vice President of Marketingno datasin datossin datos

7.2yrs

Permanencia media

57yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de USNA es experimentado (7.2 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Kevin Guest
Executive Chairman6.9yrsUS$3.91m0.063%
$ 529.3k
Myron Wentz
Founder & Chairman Emeritus3.9yrssin datos40.97%
$ 342.7m
Gilbert Fuller
Lead Independent Director15.6yrsUS$251.60k0.0026%
$ 21.3k
Peggie Pelosi
Independent Director5.3yrsUS$231.40k0.017%
$ 145.5k
Timothy Wood
Independent Director4.5yrsUS$218.64k0.027%
$ 228.3k
Christine Wood
Member of Scientific Advisory Councilno datasin datossin datos
Monica Lewis
Member of Scientific Advisory Councilno datasin datossin datos
Peter Rugg
Chairperson of Scientific Advisory Council20.3yrssin datossin datos
Bart Moore
Member of Scientific Advisory Councilno datasin datossin datos
Heather Tick
Member of Scientific Advisory Councilno datasin datossin datos
Frederic Winssinger
Independent Director7.9yrsUS$233.84k0.017%
$ 138.0k
J. Nixon
Independent Director1.8yrsUS$118.10k0.015%
$ 125.5k

6.1yrs

Permanencia media

67yo

Promedio de edad

Junta con experiencia: La junta directiva de USNA se considera experimentada (6.1 años de antigüedad promedio).